JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB40763

Anti-CD45 抗体 [EP322Y]

Anti-CD45 antibody [EP322Y]

5

(14 Reviews)

|

(110 Publications)

Anti-CD45 antibody [EP322Y] (ab40763) is a rabbit monoclonal antibody detecting CD45 in Western Blot, Flow Cytometry (Intra), IHC-P, ICC/IF. Suitable for Human.

- Biophysical QC for unrivalled batch-batch consistency
- Over 50 publications
- Trusted since 2006

別名を表示する

CD45, PTPRC, Receptor-type tyrosine-protein phosphatase C, Leukocyte common antigen, T200, L-CA

15 Images
Flow Cytometry (Intracellular) - Anti-CD45 antibody [EP322Y] (AB40763)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-CD45 antibody [EP322Y] (AB40763)

Overlay histogram showing Jurkat (Human T cell leukemia cell line from peripheral blood) cells fixed in 4% PFA and stained with purified ab40763 at a dilution of 1 in 20 (red line).

The secondary antibody used was FITC goat anti-rabbit at a dilution of 1 in 500. Rabbit monoclonal IgG was used as an isotype control (black line) and cells incubated in the absence of both primary and secondary antibody were used as a negative control (blue line).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)

Unpurified ab40763 showing positive staining in normal colon lymphoid cells tissue.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)

Unpurified ab40763 showing positive staining in normal spleen tissue.

Immunocytochemistry/ Immunofluorescence - Anti-CD45 antibody [EP322Y] (AB40763)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-CD45 antibody [EP322Y] (AB40763)

Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized Jurkat cells labelling CD45 with ab40763 at 1/100 (6.1 ug/ml) dilution, followed by ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) antibody at 1/1000 2ug/ml dilution (Green). Confocal image showing membranouse staining in Jurkat cells and no staining in 293T cells. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) at 1000 2ug/ml dilution.

Flow Cytometry (Intracellular) - Anti-CD45 antibody [EP322Y] (AB40763)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-CD45 antibody [EP322Y] (AB40763)

Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized 293T (Human embryonic kidney epithelial cell, Left) / Jurkat (Human T cell leukemia T lymphocyte, Right) cells labelling CD45 with ab40763 at 1/500 dilution (0.1ug)/ Right compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody. Negative control : 293T. (PMID : 16005866)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)

Immunohistochemical staining of paraffin embedded human tonsil with purified ab40763 at a working dilution of 1/250.

The secondary antibody used is HRP goat anti-rabbit IgG H&L (ab97051) at 1/500. The sample is counterstained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0.

PBS was used instead of the primary antibody as the negative control (shown in the inset).

Flow Cytometry (Intracellular) - Anti-CD45 antibody [EP322Y] (AB40763)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-CD45 antibody [EP322Y] (AB40763)

Flow cytometry staining of human peripheral blood mononuclear cells (PBMCs) with ab40763 (right) or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (left).

PBMCs were incubated for 30 min on ice in 1x PBS containing 10 µg/ml human IgG and 10 % normal goat serum to block FC receptors and non-specific protein-protein interactions. Cells were fixed and permeabilised with BD Cytofix/Cytoperm™ for 20 min, followed by the addition of antibody ab40763 or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (1x 106 in 100 µl at 0.2 μg/ml (1/10,500)) for 30 min at 22°C.

The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C.

Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter. Events were gated on live cells.

Western blot - Anti-CD45 antibody [EP322Y] (AB40763)
  • WB

Lab

Western blot - Anti-CD45 antibody [EP322Y] (AB40763)

This blot was produced using a 3-8% Tris Acetate gel under the TA buffer system. The gel was run at 150V for 60 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes.

The membrane was then blocked for an hour using 3% milk before being incubated with ab40763 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution ab133406.

All lanes:

Western blot - Anti-CD45 antibody [EP322Y] (ab40763) at 1/5000 dilution

All lanes:

Jurkat (Human T cell lymphoblast-like cell line) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 147 kDa

Observed band size: 200 kDa

true

Exposure time: 8min

Western blot - Anti-CD45 antibody [EP322Y] (AB40763)
  • WB

Lab

Western blot - Anti-CD45 antibody [EP322Y] (AB40763)

Blocking/Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-CD45 antibody [EP322Y] (ab40763) at 1/5000 dilution

All lanes:

Raji (Human Burkitt's lymphoma cell line) cell lysate at 20 µg

Secondary

All lanes:

HRP goat anti-rabbit IgG (H+L) at 1/50000 dilution

Predicted band size: 147 kDa

Observed band size: 200 kDa

false

Western blot - Anti-CD45 antibody [EP322Y] (AB40763)
  • WB

Lab

Western blot - Anti-CD45 antibody [EP322Y] (AB40763)

False colour image of Western blot : Anti-CD45 antibody [EP322Y] staining at 1/5000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab40763 was shown to bind specifically to CD45. A band was observed at 160-220 kDa in wild-type Jurkat cell lysates with no signal observed at this size in PTPRC CRISPR-Cas9 edited cell line ab274932 (CRISPR-Cas9 edited cell lysate ab274990). The band observed in the CRISPR-Cas9 edited lysate lane below 160-220 kDa is likely to represent a truncated form of CD45. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and PTPRC CRISPR-Cas9 edited Jurkat cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-CD45 antibody [EP322Y] (ab40763) at 1/5000 dilution

Lane 1:

Wild-type Jurkat cell lysate at 20 µg

Lane 2:

PTPRC CRISPR-Cas9 edited Jurkat cell lysate at 20 µg

Lane 3:

THP-1 cell lysate at 20 µg

Lane 4:

MCF7 cell lysate at 20 µg

Predicted band size: 147 kDa

Observed band size: 160-220 kDa

false

Western blot - Anti-CD45 antibody [EP322Y] (AB40763)
  • WB

Lab

Western blot - Anti-CD45 antibody [EP322Y] (AB40763)

False colour image of Western blot : Anti-CD45 antibody [EP322Y] staining at 1/5000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab40763 was shown to bind specifically to CD45. A band was observed at 160-220 kDa in wild-type Jurkat cell lysates with no signal observed at this size in PTPRC knockout cell line ab274932 (knockout cell lysate ab274990). The band observed in the knockout lysate lane below 160-220 kDa is likely to represent a truncated form of CD45. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and PTPRC knockout Jurkat cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-CD45 antibody [EP322Y] (ab40763) at 1/5000 dilution

Lane 1:

Wild-type Jurkat cell lysate at 20 µg

Lane 2:

PTPRC knockout Jurkat cell lysate at 20 µg

Lane 3:

THP-1 cell lysate at 20 µg

Lane 4:

MCF7 cell lysate at 20 µg

false

Western blot - Anti-CD45 antibody [EP322Y] (AB40763)
  • WB

Lab

Western blot - Anti-CD45 antibody [EP322Y] (AB40763)

Blocking/Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-CD45 antibody [EP322Y] (ab40763) at 1/5000 dilution

All lanes:

HuT-78 cell lysate at 20 µg

Secondary

All lanes:

HRP goat anti-rabbit IgG (H+L) at 1/50000 dilution

Predicted band size: 147 kDa

Observed band size: 200 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)

Unpurified ab40763 showing negative staining in skeletal muscle tissue.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)

Unpurified ab40763 showing negative staining in normal kidney tissue.

OI-RD Scanning - Anti-CD45 antibody [EP322Y] (AB40763)
  • OI-RD Scanning

Supplier Data

OI-RD Scanning - Anti-CD45 antibody [EP322Y] (AB40763)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

関連する標識済み抗体及び組成の異なる製品 (6)

  • Carrier free

    Anti-CD45 antibody [EP322Y] - BSA and Azide free

  • 578 PE

    PE Anti-CD45 antibody [EP322Y]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-CD45 antibody [EP322Y]

  • 660 APC

    APC Anti-CD45 antibody [EP322Y]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-CD45 antibody [EP322Y]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-CD45 antibody [EP322Y]

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EP322Y

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

WB, IHC-P, ICC/IF, Flow Cyt (Intra)

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特異性

This antibody recognizes cytoplasmic domain of CD45.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/15 - 1/20", "FlowCytIntra-species-notes": "<p><a href='/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p><p>Permeabilization and intracellular staining is necessary.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/250", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

製品の詳細

Anti-CD45 antibody [EP322Y] (ab40763) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P and WB.

Abcam's high quality manufacturing and validation processes ensure Anti-CD45 antibody [EP322Y] (ab40763) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.

Anti-CD45 antibody [EP322Y] (ab40763) has 13 independent reviews from customers.

Anti-CD45 antibody [EP322Y] (ab40763) specifically detects CD45 (UniProt ID: P08575; Molecular weight: 145kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).

Conjugation-ready, carrier free format available for antibody clone EP322Y - ab214437.

Antibody clone EP322Y is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, PE, PerCP, APC, Alexa Fluor® 594 (ab200315, ab200317, ab214501, ab220298, ab221245, ab303598).

CD45 regulates immune cell signaling and is crucial in the development and function of immune cells, with alterations linked to various immunodeficiencies and autoimmune diseases.

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

CD45 also known as Protein tyrosine phosphatase receptor type C (PTPRC) is a transmembrane glycoprotein with a molecular mass ranging between 180-240 kDa depending on its isoform. It is expressed on the surface of almost all hematopoietic cells except for mature erythrocytes and platelets. CD45 has a critical role in regulating antigen receptor signaling by modifying kinases involved in signal transduction and it is essential in lymphocyte development and activation. Because of its broad expression on immune cells CD45 is a valuable marker for differentiating various immune cell types in assays like flow cytometry and immunohistochemistry (IHC) often referred to as CD45 stain.
Biological function summary

CD45 acts by regulating tyrosine phosphorylation in the immune cell signaling context participating directly in signal transduction. It functions by dephosphorylating specific phosphotyrosine residues on various proteins modulating the signaling threshold required for lymphocyte activation. Although not known to be part of a protein complex CD45 itself shows isoform variation that associates with specific immune cell types impacting their function. Importantly CD45 interacts with multiple signaling molecules to affect cell growth and differentiation.

Pathways

Scientists associate CD45 with signaling pathways such as the T-cell receptor (TCR) and B-cell receptor (BCR) signaling. CD45 modulates the activity of Src family kinases important elements in these pathways making it essential for effective immune response and tolerance. Furthermore interactions between CD45 and proteins like Lck in T-cells or Lyn in B-cells highlight its pivotal role in executing its signaling functions.

Scientists often link CD45 to immune-related conditions including autoimmunity and leukemia. In autoimmune diseases altered CD45 expression or activity can disrupt normal immune function contributing to pathogenesis. In leukemia CD45 expression levels can assist in disease classification and prognosis as it interacts with proteins involved in cell cycle regulation. The anti-CD45 antibodies can provide diagnostic and therapeutic avenues highlighting their utility in disease management.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Protein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor (PubMed : 35767951). Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN. Dephosphorylates LYN, and thereby modulates LYN activity (By similarity). Interacts with CLEC10A at antigen presenting cell-T cell contact; CLEC10A on immature dendritic cells recognizes Tn antigen-carrying PTPRC/CD45 receptor on effector T cells and modulates T cell activation threshold to limit autoreactivity.. (Microbial infection) Acts as a receptor for human cytomegalovirus protein UL11 and mediates binding of UL11 to T-cells, leading to reduced induction of tyrosine phosphorylation of multiple signaling proteins upon T-cell receptor stimulation and impaired T-cell proliferation.
See full target information PTPRC

文献 (110)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in oncology 15:1632245 PubMed40772038

2025

Complementary detection strategies for circulating tumor cells in breast cancer: clinical implications of combining immunofluorescence and cytopathological staining.

Applications

Unspecified application

Species

Unspecified reactive species

Tanja Jesenko,Cvetka Grasic Kuhar,Ziva Pisljar,Simona Miceska,Veronika Kloboves-Prevodnik,Maja Cemazar

Physiological reports 13:e70494 PubMed40746221

2025

APE1/Ref-1 inhibition via APX3330 lowers monocyte/macrophage infiltration without ameliorating the structure and function of dystrophic mdx hindlimb muscles.

Applications

Unspecified application

Species

Unspecified reactive species

Hannah Lalunio,Craig A Goodman,Nicole Stupka,Nicholas Giourmas,Danielle A Debruin,Lauren Sahakian,Kulmira Nurgali,Alan Hayes

Discover oncology 16:1419 PubMed40720004

2025

BRD8 inhibits colorectal cancer progression through TGF-β1-mediated tumor-associated macrophage recruitment.

Applications

Unspecified application

Species

Unspecified reactive species

Liang Xu,Yejia Mo,Bingqi Yu,Sunfu Fan

British journal of cancer 133:756-770 PubMed40646287

2025

Targeting ribosomes reprograms the tumour microenvironment and augments cancer immunotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Kaisa Cui,Bingxin Liu,Liang Gong,Quan Wan,Hong Tang,Zhicheng Gong,Renhui Shen,Chao Wang,Qiang Zhang,Qilin Li,Yizhun Zhu,Youming Zhang,Xiaojie Lu

Translational oncology 56:102381 PubMed40199156

2025

Tumor-derived immunoglobulin-like transcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Leirong Wang,Qing Li,Yanxin Sun,Shuyun Wang,Xuebing Fu,Xiufen Wang,Yan Zheng,Aiqin Gao,Yuping Sun,Juan Li

Journal of inflammation research 18:4551-4565 PubMed40191096

2025

Protective Effects of Qingre Sanjie Jiaonang on Pulmonary Fibrosis: A Pilot Study.

Applications

Unspecified application

Species

Unspecified reactive species

Liu-Cheng Li,Zhi-Hui Zhang,Lei Liu,Bo Chen,Ye-Cheng Jin,Yu-Zhen Wang

BMC cancer 25:593 PubMed40169956

2025

Targeting CD276: a promising strategy for CAR-NK cell immunotherapy in human oral tongue squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Shiyuan Liu,Tian Guan,Futian Yang,Honglei Zhang,Yao Yao,Jiman Huang,Pengfei Zhao,Wei Huang,Tailiang Wu,Hui Lin,Ting Fu,Shaoyu Chen,Pengzhan Dai,Zhechun Ding,Dongmei Chen,Wei Li,Haoyu Zeng,Xianjun Zhang

Science advances 11:eadr4588 PubMed40153501

2025

mutation drives dopamine dysregulation and synaptic imbalance in Tourette's syndrome.

Applications

Unspecified application

Species

Unspecified reactive species

Junkai Lv,Shiqi Liang,Pengwei Qin,Xinlu Liu,Xiangyu Ge,Yiqing Guo,Shili Xia,Wei Jing,Youming Lu,Tongmei Zhang,Hao Li

Nature communications 16:2974 PubMed40140646

2025

Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression.

Applications

Unspecified application

Species

Unspecified reactive species

Chenfei Lu,Tao Kang,Junxia Zhang,Kailin Yang,Yang Liu,Kefan Song,Qiankun Lin,Deobrat Dixit,Ryan C Gimple,Qian Zhang,Zhumei Shi,Xiao Fan,Qiulian Wu,Daqi Li,Danyang Shan,Jiancheng Gao,Danling Gu,Hao You,Yangqing Li,Junlei Yang,Linjie Zhao,Zhixin Qiu,Hui Yang,Ningwei Zhao,Wei Gao,Weiwei Tao,Yingmei Lu,Yun Chen,Jing Ji,Zhe Zhu,Chunsheng Kang,Jianghong Man,Sameer Agnihotri,Qianghu Wang,Fan Lin,Xu Qian,Stephen C Mack,Zhibin Hu,Chaojun Li,Michael D Taylor,Ning Liu,Nu Zhang,Ming Lu,Yongping You,Jeremy N Rich,Wei Zhang,Xiuxing Wang

Clinical and translational medicine 15:e70175 PubMed39934971

2025

Immune profiling of the macroenvironment in colorectal cancer unveils systemic dysfunction and plasticity of immune cells.

Applications

Unspecified application

Species

Unspecified reactive species

Haoxian Ke,Peisi Li,Zhihao Li,Xian Zeng,Chi Zhang,Shuzhen Luo,Xiaofang Chen,Xinlan Zhou,Shichen Dong,Shaopeng Chen,Junfeng Huang,Ming Yuan,Runfeng Yu,Shubiao Ye,Tuo Hu,Zhonghui Tang,Dongbin Liu,Kui Wu,Xianrui Wu,Ping Lan
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com